Photo: avlxyz, Flickr
Speed-to-market isn't just a slogan for manufacturing product. The concept is now being applied to genetically modified Atlantic salmon that grow to maturity in a 16 to 18 months, rather than the typical three years needed for conventionally farmed salmon.
According to an article in The New York Times, a Massachusetts-based biotech company, AquaBounty Technologies, has boosted the salmon's productivity by enhancing the fish with a growth-hormone gene from a Chinook salmon and a "genetic on-switch" from a related species, the ocean pout. That on-switch allows the salmon to continue making growth hormones during cold weather, something non-genetically modified salmon do not do.
According to a company press release, the Center for Veterinary Medicine (an agency within the FDA) has completed reviewing several sections of AquaBounty's application. The company has been seeking FDA approval for many years, and says it expects the formal process for approval of the genetically modified salmon to go forward.
AquaBounty says the genetically modified salmon will be made up of sterile females grown in closed-containment tanks, eliminating the risk of escapement or accidental reproduction with wild salmon.













